Literature DB >> 8223967

Endothelin-1 exacerbates focal cerebral ischemia without exerting neurotoxic action in vitro.

R Nikolov1, A Rami, J Krieglstein.   

Abstract

In a model of focal cerebral ischemia in mice, intracisternal injection of 5 and 10 pmol/mouse endothelin-1 significantly increased the infarcted surface area by 15.5% and by 23.5%, respectively. Endothelin-1 (0.01, 1, and 100 nmol/l) added to the primary neuronal cultures of chick embryo cerebral hemispheres for 1 h and 24 h did not influence the viability of the neurons or the protein content of the cultures. When applied simultaneously with 1 mmol/l sodium cyanide for 30 min, endothelin-1 (0.01, 1, and 100 nM) did not modify the hypoxia-induced changes. The results show that exogenously applied endothelin-1 could exacerbate cerebral ischemia, probably due to its vasoconstrictive properties and not to a direct neurotoxic effect.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8223967     DOI: 10.1016/0926-6917(93)90044-q

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  4 in total

1.  Endothelin receptor antagonist preserves microvascular perfusion and reduces ischemic brain damage following permanent focal ischemia.

Authors:  D A Dawson; H Sugano; R M McCarron; J M Hallenbeck; M Spatz
Journal:  Neurochem Res       Date:  1999-12       Impact factor: 3.996

2.  Intraspinal application of endothelin results in focal ischemic injury of spinal gray matter and restricts the differentiation of engrafted neural stem cells.

Authors:  Richard L Benton; John P Woock; Evelyne Gozal; Michal Hetman; Scott R Whittemore
Journal:  Neurochem Res       Date:  2005 Jun-Jul       Impact factor: 3.996

3.  Ribosomal S6 kinase regulates ischemia-induced progenitor cell proliferation in the adult mouse hippocampus.

Authors:  Kate Karelina; Diego Alzate-Correa; Karl Obrietan
Journal:  Exp Neurol       Date:  2013-12-01       Impact factor: 5.330

4.  A white matter stroke model in the mouse: axonal damage, progenitor responses and MRI correlates.

Authors:  Elif G Sozmen; Arunima Kolekar; Leif A Havton; S Thomas Carmichael
Journal:  J Neurosci Methods       Date:  2009-03-31       Impact factor: 2.390

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.